<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Cheminform</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Cheminform</journal-id>
    <journal-title-group>
      <journal-title>Journal of Cheminformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-2946</issn>
    <publisher>
      <publisher-name>Springer International Publishing</publisher-name>
      <publisher-loc>Cham</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7238540</article-id>
    <article-id pub-id-type="publisher-id">439</article-id>
    <article-id pub-id-type="doi">10.1186/s13321-020-00439-2</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>SYBA: Bayesian estimation of synthetic accessibility of organic compounds</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8923-1627</contrib-id>
        <name>
          <surname>Voršilák</surname>
          <given-names>Milan</given-names>
        </name>
        <address>
          <email>milan.vorsilak@img.cas.cz</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4593-1525</contrib-id>
        <name>
          <surname>Kolář</surname>
          <given-names>Michal</given-names>
        </name>
        <address>
          <email>kolarmi@img.cas.cz</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7787-8653</contrib-id>
        <name>
          <surname>Čmelo</surname>
          <given-names>Ivan</given-names>
        </name>
        <address>
          <email>ivan.cmelo@vscht.cz</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2577-5163</contrib-id>
        <name>
          <surname>Svozil</surname>
          <given-names>Daniel</given-names>
        </name>
        <address>
          <email>daniel.svozil@vscht.cz</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.448072.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0635 6059</institution-id><institution>CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Department of Informatics and Chemistry, Faculty of Chemical Technology, </institution><institution>University of Chemistry and Technology Prague, </institution></institution-wrap>Technická 5, 166 28 Prague 6, Czech Republic </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.418827.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 870X</institution-id><institution>CZ-OPENSCREEN: National Infrastructure for Chemical Biology, </institution><institution>Institute of Molecular Genetics of theCzech Academy of Sciences, </institution></institution-wrap>Vídeňská 1083, 142 20 Prague 4, Czech Republic </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.418827.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 870X</institution-id><institution>Laboratory of Genomics and Bioinformatics, </institution><institution>Institute of Molecular Genetics, Czech of the Academy of Sciences, </institution></institution-wrap>Vídeňská 1083, 142 20 Prague 4, Czech Republic </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.448072.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0635 6059</institution-id><institution>Department of Informatics and Chemistry, Faculty of Chemical Technology, </institution><institution>University of Chemistry and Technology Prague, </institution></institution-wrap>Technická 5, 166 28 Prague 6, Czech Republic </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>20</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>20</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>12</volume>
    <elocation-id>35</elocation-id>
    <history>
      <date date-type="received">
        <day>31</day>
        <month>1</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>9</day>
        <month>5</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">SYBA (SYnthetic Bayesian Accessibility) is a fragment-based method for the rapid classification of organic compounds as easy- (ES) or hard-to-synthesize (HS). It is based on a Bernoulli naïve Bayes classifier that is used to assign SYBA score contributions to individual fragments based on their frequencies in the database of ES and HS molecules. SYBA was trained on ES molecules available in the ZINC15 database and on HS molecules generated by the Nonpher methodology. SYBA was compared with a random forest, that was utilized as a baseline method, as well as with other two methods for synthetic accessibility assessment: SAScore and SCScore. When used with their suggested thresholds, SYBA improves over random forest classification, albeit marginally, and outperforms SAScore and SCScore. However, upon the optimization of SAScore threshold (that changes from 6.0 to – 4.5), SAScore yields similar results as SYBA. Because SYBA is based merely on fragment contributions, it can be used for the analysis of the contribution of individual molecular parts to compound synthetic accessibility. SYBA is publicly available at <ext-link ext-link-type="uri" xlink:href="https://github.com/lich-uct/syba">https://github.com/lich-uct/syba</ext-link> under the GNU General Public License.</p>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Synthetic accessibility</kwd>
      <kwd>Bayesian analysis</kwd>
      <kwd>Bernoulli naïve Bayes</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001823</institution-id>
            <institution>Ministerstvo Školství, Mládeže a Tělovýchovy</institution>
          </institution-wrap>
        </funding-source>
        <award-id>RVO 68378050-KAV-NPUI</award-id>
        <award-id>RVO 68378050-KAV-NPUI</award-id>
        <award-id>RVO 68378050-KAV-NPUI</award-id>
        <award-id>LM2018130</award-id>
        <award-id>LM2018130</award-id>
        <award-id>LM2018130</award-id>
        <award-id>20/2015</award-id>
        <principal-award-recipient>
          <name>
            <surname>Voršilák</surname>
            <given-names>Milan</given-names>
          </name>
          <name>
            <surname>Čmelo</surname>
            <given-names>Ivan</given-names>
          </name>
          <name>
            <surname>Svozil</surname>
            <given-names>Daniel</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Operational Programme Research, Development and Education</institution>
        </funding-source>
        <award-id>CZ.02.1.01/0.0/0.0/16_019/0000785</award-id>
        <principal-award-recipient>
          <name>
            <surname>Voršilák</surname>
            <given-names>Milan</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par17">Chemical space available for the generation of new molecules is huge [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref>], making the synthesis and testing of all possible compounds impractical. Therefore chemists, both experimental and computational, developed tools and approaches for the exploration of chemical space with the aim to identify new compounds with desirable physico-chemical, biological and pharmacological properties [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR12">12</xref>]. A major in silico method for chemical space exploration is de novo molecular design in which new virtual molecules are assembled from scratch [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. An essential requirement for de novo designed compounds is their synthetic accessibility. Synthetic accessibility is commonly incorporated into de novo design programs by employing chemical strategies that guide an assembly process. For example, the connections between certain atom types can be disallowed [<xref ref-type="bibr" rid="CR19">19</xref>], established chemical reactions can be used to connect individual molecular building blocks [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>] or the retrosynthetic rules can be directly incorporated into the assembly process [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>].</p>
    <p id="Par18">The latest development in de novo molecular design are molecular generators based on deep learning approaches [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref>]. These typically construct new molecules not by assembling the building blocks, but by producing chemically feasible SMILES strings [<xref ref-type="bibr" rid="CR27">27</xref>–<xref ref-type="bibr" rid="CR32">32</xref>]. The generators are able to produce millions of virtual compounds, synthetic accessibility of which has to be quickly and efficiently assessed. Quick synthetic accessibility assessment can be based [<xref ref-type="bibr" rid="CR33">33</xref>] on molecule’s complexity that is typically calculated [<xref ref-type="bibr" rid="CR34">34</xref>–<xref ref-type="bibr" rid="CR37">37</xref>] from the number of atoms, bonds, rings, and/or hard-to-synthesize motifs, such as chiral centers or uncommon ring fusions. However, the definition of molecular complexity is ambiguous and context dependent [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. The structural complexity is not equivalent to the synthetic one as complexity-based metrics do not incorporate any information about starting materials and tend to remove molecules that can be synthesized from already existing complex precursors [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. A better way of synthetic accessibility assessment is to use the complexity of the synthetic route [<xref ref-type="bibr" rid="CR42">42</xref>]. Based on this principle, SCScore, a data-driven metric designed to describe real syntheses, was developed recently [<xref ref-type="bibr" rid="CR43">43</xref>]. SCScore is based on the idea that reaction products are synthetically more complex than reactants. To quantify this, a deep feed-forward neural network, that assigns a synthetic complexity score between 1 and 5, was trained on 22 million reactant-product pairs from the Reaxys database [<xref ref-type="bibr" rid="CR44">44</xref>]. Using the hinge loss objective function, that supports the separation between scores in each reactant–product pair, the model learns synthetic complexity score that correlates with the number of reaction steps, but does not rely on the availability of reaction database or organic chemist ranking.</p>
    <p id="Par19">SAScore [<xref ref-type="bibr" rid="CR45">45</xref>], another popular and rapid method for synthetic accessibility assessment, is based on the analysis of ECFP4 [<xref ref-type="bibr" rid="CR46">46</xref>] fragments obtained from one million compounds randomly selected from the PubChem database [<xref ref-type="bibr" rid="CR47">47</xref>]. The main idea of SAScore is that when a molecular fragment occurs often in the PubChem database, it contributes to the synthetic accessibility of a molecule more than a less frequently occurring fragment. Each fragment is assigned a numerical score, frequent fragments have positive scores and less frequent fragments have negative scores. In addition to the fragment score, SAScore consists of a complexity penalty and symmetry bonus. These terms penalize nonstandard structural motives such as macrocycles, stereo centers, spiro and bridge atom, but reward the symmetry of a structure. SAScore acquires values between 1 (easy to make) and 10 (very difficult to make), where 6.0 is suggested by the authors [<xref ref-type="bibr" rid="CR45">45</xref>] as a threshold to distinguish between easy- and hard-to-synthesize compounds. SAScore is a popular high-throughput measure and proved to be a very useful tool in many cheminformatics applications [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR50">50</xref>].</p>
    <p id="Par20">In the present work, we further expand on main concepts of SAScore construction. We developed SYBA (SYnthetic Bayesian Accessibility), a rapid fragment-based score derived using Bayesian probabilistic modeling. Fragment contributions to SYBA are calculated not only from fragments present in synthetically accessible molecules, but also from fragments appearing in hard-to-synthesize molecules.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>SYBA score derivation</title>
      <p id="Par21">SYBA is a Bernoulli naïve Bayes classifier based on the frequency of molecular fragments that are present in the database of easy-to-synthesize (ES) and hard-to-synthesize (HS) molecules and on the assumption of the independence of molecular fragments. Though such assumption is bold, it was shown to provide surprisingly good results in many cheminformatics studies [<xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR55">55</xref>].</p>
      <p id="Par22">Each compound is represented by a binary fingerprint <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\varvec{F} = \left[ {f_{1} ,f_{2} , \ldots ,f_{M} } \right]$$\end{document}</tex-math><mml:math id="M2"><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq1.gif"/></alternatives></inline-formula> of length <italic>M</italic> where <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f_{i}$$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq2.gif"/></alternatives></inline-formula> indicates the presence (<inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f_{i} = 1$$\end{document}</tex-math><mml:math id="M6"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq3.gif"/></alternatives></inline-formula>) or absence (<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f_{i} = 0$$\end{document}</tex-math><mml:math id="M8"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq4.gif"/></alternatives></inline-formula>) of the specific fragment <italic>i</italic> in the compound. SYBA uses this fingerprint to assign the molecule to a class <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$C \in \left\langle {{\text{ES}},{\text{HS}}} \right\rangle$$\end{document}</tex-math><mml:math id="M10"><mml:mrow><mml:mi>C</mml:mi><mml:mo>∈</mml:mo><mml:mfenced close="〉" open="〈"><mml:mrow><mml:mtext>ES</mml:mtext><mml:mo>,</mml:mo><mml:mtext>HS</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq5.gif"/></alternatives></inline-formula>. The calculation is based on the Bayes theorem<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {C |\varvec{F}} \right) = \frac{{p\left( {\varvec{F}|C} \right) p\left( C \right)}}{{p\left( \varvec{F} \right)}},$$\end{document}</tex-math><mml:math id="M12" display="block"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi>C</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:mfenced><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>C</mml:mi></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq6"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {C |\varvec{F}} \right)$$\end{document}</tex-math><mml:math id="M14"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi>C</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq6.gif"/></alternatives></inline-formula> is the posterior probability that a compound with a certain set of molecular fragments <bold><italic>F</italic></bold> belongs to the class <inline-formula id="IEq7"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$C$$\end{document}</tex-math><mml:math id="M16"><mml:mi>C</mml:mi></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq7.gif"/></alternatives></inline-formula>. The likelihood <inline-formula id="IEq8"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p(\varvec{F}|C)$$\end{document}</tex-math><mml:math id="M18"><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq8.gif"/></alternatives></inline-formula> is the conditional probability that a compound from the class <inline-formula id="IEq9"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$C$$\end{document}</tex-math><mml:math id="M20"><mml:mi>C</mml:mi></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq9.gif"/></alternatives></inline-formula> contains a set of molecular fragments <bold><italic>F</italic></bold>. The marginal probabilities <inline-formula id="IEq10"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( \varvec{F} \right)$$\end{document}</tex-math><mml:math id="M22"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq10.gif"/></alternatives></inline-formula> and <inline-formula id="IEq11"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( C \right)$$\end{document}</tex-math><mml:math id="M24"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mi>C</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq11.gif"/></alternatives></inline-formula> express our belief to observe a set of molecular fragments <bold><italic>F</italic></bold> and the molecule that belongs to the class <inline-formula id="IEq12"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$C$$\end{document}</tex-math><mml:math id="M26"><mml:mi>C</mml:mi></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq12.gif"/></alternatives></inline-formula>.</p>
      <p id="Par23">The SYBA score is defined as the logarithm of the ratio of the posterior probabilities that the molecule belongs to the ES and HS classes,<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{SYBA}}\left( \varvec{F} \right) = \ln \left( {\frac{{p\left( {{\text{ES|}}\varvec{F}} \right)}}{{p\left( {{\text{HS|}}\varvec{F}} \right)}}} \right) .$$\end{document}</tex-math><mml:math id="M28" display="block"><mml:mrow><mml:mtext>SYBA</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mo>ln</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>ES|</mml:mtext><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mtext>HS|</mml:mtext><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>Using Eq. <xref rid="Equ1" ref-type="">1</xref>, the SYBA score can be expressed as<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{SYBA}}\left( \varvec{F} \right) = \ln \left( {\frac{{p\left( {\text{ES}} \right)}}{{p\left( {\text{HS}} \right)}}} \right) + \ln \left( {\frac{{p\left( {\varvec{F} | {\text{ES}}} \right)}}{{p\left( {\varvec{F} | {\text{HS}}} \right)}}} \right) .$$\end{document}</tex-math><mml:math id="M30" display="block"><mml:mrow><mml:mtext>SYBA</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mo>ln</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mtext>ES</mml:mtext></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mtext>HS</mml:mtext></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>+</mml:mo><mml:mo>ln</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mtext>ES</mml:mtext></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mtext>HS</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula>In the data set SYBA was derived from (further referred to as the training data set S), ES and HS compounds are represented evenly, the priors <inline-formula id="IEq13"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {\text{ES}} \right)$$\end{document}</tex-math><mml:math id="M32"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mtext>ES</mml:mtext></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq13.gif"/></alternatives></inline-formula> and <inline-formula id="IEq14"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {\text{HS}} \right)$$\end{document}</tex-math><mml:math id="M34"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mtext>HS</mml:mtext></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq14.gif"/></alternatives></inline-formula> are thus equal and the term <inline-formula id="IEq15"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\ln \left( {\frac{{p\left( {\text{ES}} \right)}}{{p\left( {\text{HS}} \right)}}} \right)$$\end{document}</tex-math><mml:math id="M36"><mml:mrow><mml:mo>ln</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mtext>ES</mml:mtext></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mtext>HS</mml:mtext></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq15.gif"/></alternatives></inline-formula> becomes zero:<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{SYBA}}\left( \varvec{F} \right) = \ln \left( {\frac{{p\left( {\varvec{F} | {\text{ES}}} \right)}}{{p\left( {\varvec{F} | {\text{HS}}} \right)}}} \right) .$$\end{document}</tex-math><mml:math id="M38" display="block"><mml:mrow><mml:mtext>SYBA</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mo>ln</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mtext>ES</mml:mtext></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mtext>HS</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>Assuming the independence of molecular fragments, the conditional probability <inline-formula id="IEq16"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {\varvec{F} |C} \right)$$\end{document}</tex-math><mml:math id="M40"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq16.gif"/></alternatives></inline-formula> factorizes to <inline-formula id="IEq17"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {\varvec{F} |C} \right) = \mathop \prod \limits_{i = 1}^{M} p(f_{i} |C)$$\end{document}</tex-math><mml:math id="M42"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mi>C</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover><mml:mi>p</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">|</mml:mo><mml:mi>C</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq17.gif"/></alternatives></inline-formula> and the SYBA score simplifies to<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{SYBA}}\left( \varvec{F} \right) = \sum\nolimits_{i = 1}^{M} {s_{i} \left( {f_{i} } \right)}$$\end{document}</tex-math><mml:math id="M44" display="block"><mml:mrow><mml:mtext>SYBA</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">F</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:msubsup><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq18"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$s_{i} \left( {f_{i} } \right)$$\end{document}</tex-math><mml:math id="M46"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq18.gif"/></alternatives></inline-formula> is the score contribution from the fragment <italic>i</italic> (SYBA fragment score) given as<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$s_{i} \left( {f_{i} } \right) = \ln \left( {\frac{{p\left( {f_{i} | {\text{ES}}} \right)}}{{p\left( {f_{i} | {\text{HS}}} \right)}}} \right).$$\end{document}</tex-math><mml:math id="M48" display="block"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mo>ln</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mtext>ES</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mtext>HS</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par24">Considering that <inline-formula id="IEq19"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p\left( {f_{i} | {\text{ES}}} \right) = 1 - p\left( {f_{i} | {\text{HS}}} \right)$$\end{document}</tex-math><mml:math id="M50"><mml:mrow><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mtext>ES</mml:mtext></mml:mrow></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mtext>HS</mml:mtext></mml:mrow></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq19.gif"/></alternatives></inline-formula>, the fragment scores <inline-formula id="IEq20"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$s_{i} \left( {f_{i} } \right)$$\end{document}</tex-math><mml:math id="M52"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq20.gif"/></alternatives></inline-formula> in Eq. <xref rid="Equ6" ref-type="">6</xref> represent logits and can be expressed using the fragment frequencies in the training data set S as<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$s_{i} \left( {f_{i} } \right) = { \ln }\frac{{N_{\text{HS}} + 2}}{{N_{\text{ES}} + 2}} + f_{i} {\text{ln}}\frac{{\left( {n_{{{\text{ES}},i}} + 1} \right)}}{{\left( {n_{{{\text{HS}},i}} + 1} \right)}} + (1 - f_{i} ) { \ln }\frac{{\left( {N_{\text{ES}} - n_{{{\text{ES}},i}} + 1} \right)}}{{\left( {N_{\text{HS}} - n_{{{\text{HS}},i}} + 1} \right)}},$$\end{document}</tex-math><mml:math id="M54" display="block"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mo>ln</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mtext>HS</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mtext>ES</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mtext>ln</mml:mtext><mml:mfrac><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mtext>ES</mml:mtext><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mtext>HS</mml:mtext><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mfrac><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>ln</mml:mo><mml:mfrac><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mtext>ES</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mtext>ES</mml:mtext><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mtext>HS</mml:mtext></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mtext>HS</mml:mtext><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq21"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$N_{\text{HS}}$$\end{document}</tex-math><mml:math id="M56"><mml:msub><mml:mi>N</mml:mi><mml:mtext>HS</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq21.gif"/></alternatives></inline-formula> is the number of HS and <inline-formula id="IEq22"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$N_{\text{ES}}$$\end{document}</tex-math><mml:math id="M58"><mml:msub><mml:mi>N</mml:mi><mml:mtext>ES</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq22.gif"/></alternatives></inline-formula> the number of ES molecules in the training data set S, <inline-formula id="IEq23"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_{{{\text{HS}},i}}$$\end{document}</tex-math><mml:math id="M60"><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mtext>HS</mml:mtext><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq23.gif"/></alternatives></inline-formula> is the number of HS molecules in the training data set S that contain the fragment <italic>i,</italic> and <inline-formula id="IEq24"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n_{{{\text{ES}},i}}$$\end{document}</tex-math><mml:math id="M62"><mml:msub><mml:mi>n</mml:mi><mml:mrow><mml:mtext>ES</mml:mtext><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq24.gif"/></alternatives></inline-formula> is the number of ES molecules in the training data set S that contain the fragment <italic>i.</italic> See Additional file <xref rid="MOESM2" ref-type="media">2</xref> for a detailed derivation. Positive <inline-formula id="IEq25"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$s_{i} \left( {f_{i} } \right)$$\end{document}</tex-math><mml:math id="M64"><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq25.gif"/></alternatives></inline-formula> means that the presence/absence of the fragment <italic>i</italic> is more probable in ES than in HS class and vice versa. Positive SYBA means that the compound belongs more likely to the ES class, while negative SYBA means that the compound belongs more likely to the HS class. The higher the absolute value of SYBA, the more evidence for the class membership is present in the molecule.</p>
    </sec>
    <sec id="Sec4">
      <title>Training set construction</title>
      <p id="Par25">The training data set S consists of two subsets: S<sub>+</sub> contains ES structures and S<sub>-</sub> contains HS structures (Fig. <xref rid="Fig1" ref-type="fig">1</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>). While ES molecules can be readily obtained, for example, from the ZINC database of purchasable compounds [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>], no equivalent database of HS molecules exists. However, HS molecules can be designed by Nonpher [<xref ref-type="bibr" rid="CR58">58</xref>], a method based on a molecular morphing approach [<xref ref-type="bibr" rid="CR59">59</xref>]. In Nonpher, a starting molecule is gradually transformed into a more complex compound using small structural perturbations, such as the addition or removal of an atom or a bond. To prevent the creation of overly complex structures, four complexity indices (Bertz [<xref ref-type="bibr" rid="CR34">34</xref>], Whitlock [<xref ref-type="bibr" rid="CR35">35</xref>], BC [<xref ref-type="bibr" rid="CR36">36</xref>] and SMCM [<xref ref-type="bibr" rid="CR37">37</xref>]) are monitored and once their respective thresholds (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1) are exceeded, Nonpher is stopped.<fig id="Fig1"><label>Fig. 1</label><caption><p>Data set summary. Training set was used to derive SYBA scores, as well as to train a random forest classifier. Training set consists of 693 353 molecules randomly selected from the ZINC15 database [<xref ref-type="bibr" rid="CR57">57</xref>] that are considered to be ES (S<sub>+</sub> data set) and of the same number of HS molecules generated by Nonpher [<xref ref-type="bibr" rid="CR58">58</xref>] (S<sub>−</sub> data set). Two test sets were used to compare the performance of SYBA, a random forest, SAScore [<xref ref-type="bibr" rid="CR45">45</xref>] and SCScore [<xref ref-type="bibr" rid="CR43">43</xref>]. Manually curated test set (T<sub>MC</sub>) contains 40 compounds (T<sub>MC-</sub> data set) considered to be HS by experienced medicinal chemists [<xref ref-type="bibr" rid="CR58">58</xref>] supplemented by 40 ES compounds randomly selected from the ZINC15 database (T<sub>MC+</sub> data set). 30 T<sub>MC</sub> data set instances differing in T<sub>MC+</sub> compounds were constructed. Computationally picked test set (T<sub>CP</sub>) consists of 3 581 HS compounds that were obtained from the GDB-17 database [<xref ref-type="bibr" rid="CR61">61</xref>] (T<sub>CP-</sub> data set) complemented by the same number of compounds randomly selected from the ZINC15 database (T<sub>CP+</sub> data set)</p></caption><graphic xlink:href="13321_2020_439_Fig1_HTML" id="MO8"/></fig></p>
      <p id="Par26">Using Nonpher, 693 353 HS molecules were generated and they form the S<sub>-</sub> data set. The S<sub>+</sub> data set, containing ES compounds, is formed by the same number of molecules randomly chosen (excluding natural products) from the ZINC15 database [<xref ref-type="bibr" rid="CR57">57</xref>] so that their distribution of the number of heavy atoms is the same as in the S<sub>-</sub> data sets. Every S<sub>+</sub> and S<sub>-</sub> molecule was fragmented using the Morgan fingerprint function in the RDKit toolkit [<xref ref-type="bibr" rid="CR60">60</xref>]. Fragments with the radius of 4 and smaller, corresponding to radial ECFP8 [<xref ref-type="bibr" rid="CR46">46</xref>] fragments, were used. This type of fragments consists of a central atom and atoms distant from the central atom up to four bonds. Besides ECFP8 fragments, the number of stereocenters was also included into SYBA as the molecules with more stereocenters are typically more difficult to synthesize. The stereo score is based, similarly to the fragment score, on the analysis of the number of stereocenters in the training set S. To obtain the stereo score, molecules were divided into 6 bins differing by the number of stereocenters (0, 1, 2, 3, 4 and 5+) and individual score contributions were calculated from Eq. <xref rid="Equ7" ref-type="">7</xref>.</p>
    </sec>
    <sec id="Sec5">
      <title>Test set construction</title>
      <p id="Par27">SYBA performance could have been assessed using a test set created in a similar way as the training set S, i.e. using HS compounds generated by Nonpher. However, such test set would be clearly biased towards chemical space covered by Nonpher. Therefore, two test sets were constructed in a conceptually different manner. First test set, further denoted as T<sub>MC</sub>, was manually curated from the literature, second test set, referred to as T<sub>CP</sub>, was computationally picked from the ZINC15 [<xref ref-type="bibr" rid="CR57">57</xref>] and GDB17 databases [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
      <p id="Par28">HS compounds in T<sub>MC</sub> (denoted as T<sub>MC−</sub>) were obtained by the analysis [<xref ref-type="bibr" rid="CR58">58</xref>] of 296 published compounds assessed by experienced medicinal chemists [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Based on original chemists’ scores, the final T<sub>MC-</sub> data set of 40 HS compounds was assembled. A complementary T<sub>MC+</sub> data set consists of 40 ES compounds selected from the ZINC15 database [<xref ref-type="bibr" rid="CR57">57</xref>] in such a way that the distribution of the number of their heavy atoms is the same as in the T<sub>MC-</sub> data set. Because small T<sub>MC</sub> size may bias the results, 30 different T<sub>MC</sub> data set instances were generated using the same 40 T<sub>MC-</sub> compounds, but different 40 T<sub>MC+</sub> compounds (Additional file <xref rid="MOESM3" ref-type="media">3</xref>).</p>
      <p id="Par29">HS compounds in the T<sub>CP</sub> test set (Additional file <xref rid="MOESM4" ref-type="media">4</xref>), denoted as T<sub>CP-</sub>, were obtained by the analysis of the publicly available subset of 50 M molecules from the GDB-17 database [<xref ref-type="bibr" rid="CR61">61</xref>]. Only molecules exceeding thresholds (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1) of all monitored complexity indices (Bertz [<xref ref-type="bibr" rid="CR34">34</xref>], Whitlock [<xref ref-type="bibr" rid="CR35">35</xref>], BC [<xref ref-type="bibr" rid="CR36">36</xref>] and SMCM [<xref ref-type="bibr" rid="CR37">37</xref>]) were considered to be HS. In total, 3 581 molecules form the T<sub>CP-</sub> data set. A complementary T<sub>CP+</sub> data set consists of the same number of compounds randomly selected from the ZINC15 database [<xref ref-type="bibr" rid="CR57">57</xref>] that follow the same size distribution as HS compounds and that, in addition, do not exceed any of the aforedescribed complexity indices. Data sets used in the present work are summarized in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.</p>
    </sec>
    <sec id="Sec6">
      <title>Performance evaluation</title>
      <p id="Par30">The performance of classification models studied in the present work was assessed by four different metrics: the classification accuracy (<italic>Acc</italic>), sensitivity (<italic>SN</italic>), specificity (<italic>SP</italic>) and area under the ROC curve (<italic>AUC</italic>). <italic>Acc</italic> gives the percentage of correctly classified samples regardless of their class.<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Accuracy }}\left( {\text{Acc}} \right) = \frac{TP + TN}{TP + TN + FN + FP}$$\end{document}</tex-math><mml:math id="M66" display="block"><mml:mrow><mml:mrow><mml:mtext>Accuracy</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mfenced close=")" open="("><mml:mtext>Acc</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula>where true positives (<italic>TP</italic>) are ES compounds predicted by a model to be ES, true negatives (<italic>TN</italic>) are HS compounds predicted to be HS, false positives (<italic>FP</italic>) are HS compounds predicted to be ES and false negatives (<italic>FN</italic>) are ES compounds predicted to be HS. The accuracy can also be evaluated for positive and negative classes independently leading to <italic>SN</italic> and <italic>SP</italic>. <italic>SN</italic> is the percentage of correctly predicted positive class compounds, while the percentage of correctly predicted negative class compounds is known as <italic>SP</italic>.</p>
      <p id="Par31"><disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Sensitivity }}\left( {\text{SN}} \right) = \frac{TP}{TP + FN}$$\end{document}</tex-math><mml:math id="M68" display="block"><mml:mrow><mml:mrow><mml:mtext>Sensitivity</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mfenced close=")" open="("><mml:mtext>SN</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\text{Specificity }}\left( {\text{SP}} \right) = \frac{TN}{TN + FP}$$\end{document}</tex-math><mml:math id="M70" display="block"><mml:mrow><mml:mrow><mml:mtext>Specificity</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mfenced close=")" open="("><mml:mtext>SP</mml:mtext></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TN</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula><italic>SN</italic> and <italic>SP</italic> can be combined in the receiver operating characteristic (ROC) curve that is the graphical representation of the trade-off between true positive rate (given as <italic>SN</italic>) and false positive rate (given as 1 − <italic>SP</italic>) over all possible thresholds (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). The area under the ROC curve (<italic>AUC</italic>) is the quantitative measure of the performance of a classifier and is equal to the probability that a classifier will rank a randomly chosen positive example higher than a randomly chosen negative example. A random classifier has <italic>AUC</italic> of 0.5, while <italic>AUC</italic> for a perfect classifier is equal to 1.<fig id="Fig2"><label>Fig. 2</label><caption><p>ROC curve and Youden index. The ROC curve (red line) is the dependency of true positive rate (it equals to SN) on false positive rate (it equals to 1-SP) at various thresholds. The random chance line represents a classifier that assigns examples into individual classes randomly. Orange shaded area represents the area under the ROC curve (AUC). The larger the AUC, the better is the overall performance of the classifier. Youden index (YI) is the point on the ROC curve that is farthest from the random chance line along the SN axis</p></caption><graphic xlink:href="13321_2020_439_Fig2_HTML" id="MO12"/></fig></p>
    </sec>
    <sec id="Sec7">
      <title>Random forest classification, SAScore and SCScore</title>
      <p id="Par32">Because of its wide adoption in various cheminformatics applications [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR64">64</xref>–<xref ref-type="bibr" rid="CR66">66</xref>], the random forest (RF) classifier with compounds encoded by 1024-bits long Morgan fingerprint with radius 2 was used as a baseline method with which SYBA, SAScore [<xref ref-type="bibr" rid="CR45">45</xref>] and SCScore [<xref ref-type="bibr" rid="CR43">43</xref>] were compared. The RF classifier was implemented in Scikit-learn [<xref ref-type="bibr" rid="CR67">67</xref>]. Two RF hyperparameters were optimized: the number of trees (50, 100, 300 and 500) and the maximum number of features considered when looking for the best split (10% out of 1024 = 102, 25% = 256, 50% = 512, 75% = 768, 100% = 1024, <inline-formula id="IEq26"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sqrt {1024} = 32$$\end{document}</tex-math><mml:math id="M72"><mml:mrow><mml:msqrt><mml:mn>1024</mml:mn></mml:msqrt><mml:mo>=</mml:mo><mml:mn>32</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq26.gif"/></alternatives></inline-formula> and <inline-formula id="IEq27"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\log_{2} \left( {1024} \right) = 10$$\end{document}</tex-math><mml:math id="M74"><mml:mrow><mml:msub><mml:mo>log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mn>1024</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>10</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13321_2020_439_Article_IEq27.gif"/></alternatives></inline-formula>). For each pair of hyperparameters, RF model was trained using the training set S and the prediction accuracy was evaluated on the test set T<sub>CP</sub> (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2, Figures S2–S8). The setting used in this work (100 trees and 32 features) represents the best trade-off between computational efficiency and prediction accuracy [<xref ref-type="bibr" rid="CR64">64</xref>]. RF was trained using the training set S (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). SAScore was calculated by the RDKit toolkit [<xref ref-type="bibr" rid="CR60">60</xref>]. SCScore code was downloaded from the public GitHub repository [<xref ref-type="bibr" rid="CR68">68</xref>].</p>
    </sec>
    <sec id="Sec8">
      <title>Classification thresholds</title>
      <p id="Par33">In SYBA, more positive value means a higher probability that the compound is ES and more negative value indicates a higher probability that the compound is HS (Eq. <xref rid="Equ4" ref-type="">4</xref>). The threshold value of zero is used to distinguish between ES and HS compounds. For SAScore, the recommended value of 6.0 [<xref ref-type="bibr" rid="CR45">45</xref>] was used as a threshold. In RF, the final prediction is based on a number of decision trees that predict either of classes. Here, 0.5 is used as a threshold, i.e., if more decision trees predict ES than HS class, a compound is classified as ES and vice versa. For SCScore [<xref ref-type="bibr" rid="CR43">43</xref>], no threshold was suggested by the authors. In such case, the threshold can be identified by the analysis of the ROC curve. A frequently used measure that enables the selection of an optimal threshold is the Youden index (<italic>YI</italic>) [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. <italic>YI</italic> is defined as<disp-formula id="Equ11"><label>11</label><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$YI = { \hbox{max} }\left( {SN + SP - 1} \right)$$\end{document}</tex-math><mml:math id="M76" display="block"><mml:mrow><mml:mi>Y</mml:mi><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mtext>max</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:mi>S</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>S</mml:mi><mml:mi>P</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="13321_2020_439_Article_Equ11.gif" position="anchor"/></alternatives></disp-formula>and ranges between 0 and 1 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). The optimal threshold value is selected by maximizing <italic>YI,</italic> i.e., by maximizing the sum of <italic>SN</italic> and <italic>SP</italic>.</p>
    </sec>
    <sec id="Sec9">
      <title>Statistical comparison of model performance</title>
      <p id="Par34">The performance of studied classification models was compared using non-parametric Cochran’s Q test [<xref ref-type="bibr" rid="CR71">71</xref>], an omnibus test for testing for differences between three or more machine learning models. In the case of the statistically significant result of Cochran’s Q test, differing pairs of classification models were identified by McNemar’s post hoc paired test [<xref ref-type="bibr" rid="CR72">72</xref>] with Benjamini–Hochberg false discovery rate adjustment [<xref ref-type="bibr" rid="CR73">73</xref>]. McNemar’s test checks if the distribution of disagreements between two methods is imbalanced. The statistical significance for all tests in the present work was assessed at the significance level α = 0.05.</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Results and discussion</title>
    <sec id="Sec11">
      <title>Chemical space covered by SYBA data sets</title>
      <p id="Par35">The examples of training set compounds are given in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figures S9–S12. In total, 3 439 074 ECFP8 fragments were obtained for ES compounds and 23 447 524 fragments for HS compounds. 458 040 fragments are common for both S + and S- subsets. 55.0% of S+ fragments and 91.7% of S− fragments are present only once in the whole data set S (singletons). Typical ES and HS fragments are shown in Figs. <xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>, fragments with very low SYBA in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S13 and compounds containing these fragments in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S14.<fig id="Fig3"><label>Fig. 3</label><caption><p>ES fragments enriched in the S<sub>+</sub> data set. Nine fragments that are most frequent in the S<sub>+</sub> data set and, at the same time, least frequent in the S<sub>-</sub> data set. <italic>s</italic><sub><italic>i</italic></sub> is SYBA fragment score. Blue circles represent each fragment central atom, yellow circles represent aromatic atoms. Fragment images were generated by the RDKit function DrawMorganEnvs()</p></caption><graphic xlink:href="13321_2020_439_Fig3_HTML" id="MO14"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>HS fragments enriched in the S- data set. Nine fragments that are most frequent in the S- data set and, at the same time, least frequent in the S<sub>+</sub> data set. s<sub>i</sub> is SYBA fragment score. Blue circles represent fragment central atom, gray circles represent aliphatic ring atoms. Fragment images were generated by the RDKit function DrawMorganEnvs()</p></caption><graphic xlink:href="13321_2020_439_Fig4_HTML" id="MO15"/></fig></p>
      <p id="Par36">Though the number of fragments in HS compounds is much larger than in ES compounds, chemical space is equally covered by both HS and ES molecules and there is no bias towards HS compounds (Fig. <xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>Chemical space coverage by ES and HS training set compounds. 3000 ES and 3000 HS compounds were randomly selected from the training set and each compound was encoded by 1024 bits long ECFP4 fingerprint. The dimensionality of the input space was reduced by SVD to 500 components that explain 85% of the variance in the data</p></caption><graphic xlink:href="13321_2020_439_Fig5_HTML" id="MO16"/></fig></p>
      <p id="Par37">The visualization of chemical space (Fig. <xref rid="Fig6" ref-type="fig">6</xref>) covered by S, T<sub>CP</sub> and T<sub>MC</sub> compounds shows that test set compounds lie within chemical space of training compounds. The examples of T<sub>CP</sub> and T<sub>MC</sub> compounds are given in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figures S15–S21.<fig id="Fig6"><label>Fig. 6</label><caption><p>Chemical space coverage by training set S and test sets T<sub>CP</sub> and T<sub>MC</sub>. T<sub>MC</sub> data set consists of 40 HS compounds and 1200 ES compounds, from S and T<sub>CP</sub> data sets random samples of 1240 compounds were generated. Each compound was encoded by 1024 bits long ECFP4 fingerprint. The dimensionality of the input space was reduced by SVD to 500 components that explain 88% of the variance in the data</p></caption><graphic xlink:href="13321_2020_439_Fig6_HTML" id="MO17"/></fig></p>
      <p id="Par38">SYBA also enables the visualization and interpretation of fragment score contributions. Each SYBA fragment score can be projected to the corresponding fragment root atom and this projection can be used to analyze which fragments contribute unfavorably to molecule synthetic accessibility (Fig. <xref rid="Fig7" ref-type="fig">7</xref>).<fig id="Fig7"><label>Fig. 7</label><caption><p>SYBA fragment score visualization. Fragment score is projected on the fragment root atom and the whole molecule is visualized as a similarity map [<xref ref-type="bibr" rid="CR74">74</xref>]. The more frequent the fragment is in the S<sub>+</sub> data set compared to the S<sub>-</sub> data set, the greener is its central atom. Similarly, the more frequent the fragment is in the S<sub>-</sub> data set compared to the S<sub>+</sub> data set, the redder is its central atom. This visualization enables to analyze the contributions of the individual parts of the molecule to its synthetic accessibility. In the HS molecule, the quaternary carbon is most problematic. Another substructure decreasing compound synthetic accessibility is a fused cyclopropane ring as can be observed both in ES and HS compounds</p></caption><graphic xlink:href="13321_2020_439_Fig7_HTML" id="MO18"/></fig></p>
    </sec>
    <sec id="Sec12">
      <title>Classifier performance on manually curated test set</title>
      <p id="Par39">The differences in classification of T<sub>MC</sub> (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) compounds using SYBA, SAScore and RF with default thresholds are statistically significant. The Cochran’s Q test <italic>p</italic> value is 2 × 10<sup>−5</sup> for the T<sub>MC</sub> test set with the smallest SYBA AUC. The results of the corresponding McNemar’s paired tests [<xref ref-type="bibr" rid="CR72">72</xref>] are summarized in Table <xref rid="Tab1" ref-type="table">1</xref>. While RF and SYBA do not differ significantly, both RF and SYBA yield significantly better results than SAScore.<table-wrap id="Tab1"><label>Table 1</label><caption><p>The results of McNemar’s two-sided paired tests for the T<sub>MC</sub> test set with the smallest SYBA AUC (AUC = 0.830)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Adjusted p-value</th></tr></thead><tbody><tr><td align="left">RF vs. SAScore</td><td char="." align="char">0.002</td></tr><tr><td align="left">RF vs. SYBA</td><td char="." align="char">1.000</td></tr><tr><td align="left">SAScore vs. SYBA</td><td char="." align="char">0.001</td></tr></tbody></table><table-wrap-foot><p>The default threshold values were used (0.0 for SYBA, 0.5 for RF, and 6.0 for SAScore). The p-values were adjusted using Benjamini–Hochberg method</p></table-wrap-foot></table-wrap></p>
      <p id="Par40">The quality measures of the classification of the compounds in the manually curated T<sub>MC</sub> test set, averaged over 30 T<sub>MC</sub> instances, are summarized in Table <xref rid="Tab2" ref-type="table">2</xref>. The corresponding confusion matrices are reported in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Panel S1 and Panel S2 and ROC curves are shown in Fig. <xref rid="Fig8" ref-type="fig">8</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>The performance of classification models for the manually curated T<sub>MC</sub> test set</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left"><italic>AUC</italic></th><th align="left"><italic>Acc</italic></th><th align="left"><italic>SN</italic></th><th align="left"><italic>SP</italic></th><th align="left">Threshold</th></tr></thead><tbody><tr><td align="left" colspan="6">Default threshold</td></tr><tr><td align="left">SYBA</td><td char="." align="char"><italic>0.903</italic></td><td char="." align="char"><italic>0.844</italic></td><td char="." align="char">0.913</td><td char="." align="char"><italic>0.775</italic></td><td char="." align="char">0.0</td></tr><tr><td align="left">SAScore</td><td char="." align="char">0.865</td><td char="." align="char">0.617</td><td char="." align="char"><italic>0.934</italic></td><td char="." align="char">0.300</td><td char="." align="char">6.0</td></tr><tr><td align="left">RF</td><td char="." align="char">0.875</td><td char="." align="char">0.819</td><td char="." align="char">0.863</td><td char="." align="char">0.775</td><td char="." align="char">0.5</td></tr><tr><td align="left" colspan="6">Optimized threshold</td></tr><tr><td align="left">SYBA</td><td char="." align="char"><italic>0.903</italic></td><td char="." align="char"><italic>0.871</italic></td><td char="." align="char"><italic>0.902</italic></td><td char="." align="char">0.840</td><td char="." align="char">19.1</td></tr><tr><td align="left">SAScore</td><td char="." align="char">0.865</td><td char="." align="char">0.859</td><td char="." align="char">0.799</td><td char="." align="char"><italic>0.919</italic></td><td char="." align="char">3.9</td></tr><tr><td align="left">SCScore</td><td char="." align="char">0.528</td><td char="." align="char">0.601</td><td char="." align="char">0.707</td><td char="." align="char">0.496</td><td char="." align="char">3.7</td></tr><tr><td align="left">RF</td><td char="." align="char">0.875</td><td char="." align="char">0.842</td><td char="." align="char">0.855</td><td char="." align="char">0.828</td><td char="." align="char">0.6</td></tr></tbody></table><table-wrap-foot><p>Quality measures <italic>AUC</italic>, <italic>Acc</italic>, <italic>SN</italic> and <italic>SP</italic>, as well as thresholds, are reported as their average values over 30 T<sub>MC</sub> instances</p></table-wrap-foot></table-wrap><fig id="Fig8"><label>Fig. 8</label><caption><p>The ROC curves of classification models for the manually curated T<sub>MC</sub> test set. Out of 30 possible T<sub>MC</sub> instances, ROC curves of the T<sub>MC</sub> test set with the smallest (left) and largest (right) SYBA AUC are shown</p></caption><graphic xlink:href="13321_2020_439_Fig8_HTML" id="MO19"/></fig></p>
      <p id="Par41">In terms of <italic>Acc</italic>, the best performing model is SYBA followed by RF and SAScore. While SYBA and RF sensitivity and specificity are well balanced, SAScore shows high sensitivity (<italic>SN</italic> = 0.934, i.e., on average 93.4% of <italic>ES</italic> compounds are predicted as <italic>ES</italic>), while its specificity (i.e., the ability to correctly classify <italic>HS</italic> compounds) is rather low (<italic>SP</italic> = 0.300). The observed high sensitivity of SAScore is not surprising as only 0.2% of ZINC structures have SAScore greater than 6.0 and out of these, only lower units were selected into the T<sub>MC+</sub> set.</p>
      <p id="Par42">For optimized thresholds, the differences between SYBA, SAScore and RF are again statistically significant (Cochran’s Q test p-value is 2 × 10<sup>−14</sup> for the T<sub>MC</sub> test set with the smallest SYBA AUC). However, McNemar’s paired test (Table <xref rid="Tab3" ref-type="table">3</xref>) identifies significant differences only between SCScore and other methods meaning that SAScore results improve significantly upon threshold optimization.<table-wrap id="Tab3"><label>Table 3</label><caption><p>The results of McNemar’s two-sided paired tests for the T<sub>MC</sub> test set with the smallest SYBA AUC (AUC = 0.830)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Adjusted p-value</th></tr></thead><tbody><tr><td align="left">RF vs. SAScore</td><td align="left">0.164</td></tr><tr><td align="left">RF vs. SCScore</td><td align="left">2 × 10<sup>−6</sup></td></tr><tr><td align="left">RF vs. SYBA</td><td align="left">0.687</td></tr><tr><td align="left">SAScore vs. SCScore</td><td align="left">1 × 10<sup>−8</sup></td></tr><tr><td align="left">SAScore vs. SYBA</td><td align="left">0.466</td></tr><tr><td align="left">SCScore vs. SYBA</td><td align="left">2 × 10<sup>−6</sup></td></tr></tbody></table><table-wrap-foot><p>The optimized threshold values were used (27.7 for SYBA, 0.5 for RF, 3.7 for SAScore, and 4.0 for SCScore). The p-values were adjusted using Benjamini–Hochberg method</p></table-wrap-foot></table-wrap></p>
      <p id="Par43">In terms of performance measures (Table <xref rid="Tab2" ref-type="table">2</xref>), the most accurate classifiers are SYBA, RF and SAScore followed afar by SCScore. Notable is the improvement of SAScore <italic>SP</italic> by 0.619 compared to the default threshold. The increase in SAScore <italic>SP</italic> comes, however, at the cost of <italic>SN</italic> that decreases by 0.135. The worst performing model, SCScore, is only slightly better (<italic>AUC</italic> = 0.528) than a random model. However, because T<sub>MC+</sub> and T<sub>MC−</sub> data sets consist of only 40 compounds each, the results must be interpreted with caution as small changes in confusion matrices lead to relatively large changes in reported metrics.</p>
    </sec>
    <sec id="Sec13">
      <title>Classifier performance on computationally picked test set</title>
      <p id="Par44">Even stronger evidence of the differences between the models is provided by the classification of compounds in the large computationally picked T<sub>CP</sub> test set (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Using the default thresholds, the differences between the classifiers are statistically significant (Cochran’s Q test p-value &lt; 10<sup>−16</sup>) and all classifiers differ significantly (Table <xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>The results of McNemar’s two-sided paired tests for the T<sub>CP</sub> test set</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Adjusted p-value</th></tr></thead><tbody><tr><td align="left">RF vs. SAScore</td><td align="left">&lt; 10<sup>−16</sup></td></tr><tr><td align="left">RF vs. SYBA</td><td align="left">&lt; 10<sup>−16</sup></td></tr><tr><td align="left">SAScore vs. SYBA</td><td align="left">&lt; 10<sup>−16</sup></td></tr></tbody></table><table-wrap-foot><p>The default threshold values were used (0.0 for SYBA, 0.5 for RF, and 6.0 for SAScore). The p-values were adjusted using Benjamini–Hochberg method</p></table-wrap-foot></table-wrap></p>
      <p id="Par45">When used with their default thresholds, both SYBA and RF are more accurate than SAScore (Table <xref rid="Tab5" ref-type="table">5</xref>, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Panel S3). Low observed SAScore accuracy (<italic>Acc</italic> = 0.665) is caused by its low specificity when almost 70% of HS compounds are predicted to be ES (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>The performance of classification models for the computationally picked T<sub>CP</sub> test set</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left"><italic>AUC</italic></th><th align="left"><italic>Acc</italic></th><th align="left"><italic>SN</italic></th><th align="left"><italic>SP</italic></th><th align="left">Threshold</th></tr></thead><tbody><tr><td align="left" colspan="6">Default threshold</td></tr><tr><td align="left">SYBA</td><td char="." align="char">0.903</td><td char="." align="char"><italic>0.962</italic></td><td char="." align="char">0.925</td><td char="." align="char"><italic>1.000</italic></td><td char="." align="char">0.0</td></tr><tr><td align="left">SAScore</td><td char="." align="char"><italic>0.999</italic></td><td char="." align="char">0.665</td><td char="." align="char"><italic>0.999</italic></td><td char="." align="char">0.331</td><td char="." align="char">6.0</td></tr><tr><td align="left">RF</td><td char="." align="char">0.995</td><td char="." align="char">0.892</td><td char="." align="char">0.784</td><td char="." align="char">0.999</td><td char="." align="char">0.5</td></tr><tr><td align="left" colspan="6">Optimized threshold</td></tr><tr><td align="left">SYBA</td><td char="." align="char">0.998</td><td char="." align="char">0.988</td><td char="." align="char">0.985</td><td char="." align="char">0.991</td><td char="." align="char">− 18.6</td></tr><tr><td align="left">SAScore</td><td char="." align="char"><italic>0.999</italic></td><td char="." align="char"><italic>0.990</italic></td><td char="." align="char"><italic>0.986</italic></td><td char="." align="char"><italic>0.993</italic></td><td char="." align="char">4.5</td></tr><tr><td align="left">SCScore</td><td char="." align="char">0.641</td><td char="." align="char">0.612</td><td char="." align="char">0.499</td><td char="." align="char">0.725</td><td char="." align="char">3.1</td></tr><tr><td align="left">RF</td><td char="." align="char">0.995</td><td char="." align="char">0.973</td><td char="." align="char">0.960</td><td char="." align="char">0.986</td><td char="." align="char">0.2</td></tr></tbody></table></table-wrap></p>
      <p id="Par46">Cochran’s Q test identifies significant differences (p-value &lt; 10<sup>−16</sup>) also if classifiers are used with the optimized thresholds. While statistically significant differences were detected within RF/SAScore and RF/SYBA pairs (Table <xref rid="Tab6" ref-type="table">6</xref>), the effect size is still rather small (Table <xref rid="Tab5" ref-type="table">5</xref>). However, the difference between SCScore and all other methods is statistically significant and large (Tables <xref rid="Tab5" ref-type="table">5</xref> and  <xref rid="Tab6" ref-type="table">6</xref>). No statistically significant difference was observed between SYBA and SAScore meaning that these two methods yield comparable results.<table-wrap id="Tab6"><label>Table 6</label><caption><p>The results of McNemar’s two-sided paired tests for the T<sub>CP</sub> test set</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Adjusted p-value</th></tr></thead><tbody><tr><td align="left">RF vs. SAScore</td><td align="left">4 × 10<sup>−15</sup></td></tr><tr><td align="left">RF vs. SCScore</td><td align="left">&lt; 10<sup>−16</sup></td></tr><tr><td align="left">RF vs. SYBA</td><td align="left">2 × 10<sup>−14</sup></td></tr><tr><td align="left">SAScore vs. SCScore</td><td align="left">&lt; 10<sup>−16</sup></td></tr><tr><td align="left">SAScore vs. SYBA</td><td align="left">0.474</td></tr><tr><td align="left">SCScore vs. SYBA</td><td align="left">&lt; 10<sup>−16</sup></td></tr></tbody></table><table-wrap-foot><p>The optimized values of threshold (− 18.6 for SYBA, 0.2 for RF, 4.5 for SAScore, 3.1 for SCScore) were used. p-values were adjusted using Benjamini–Hochberg method</p></table-wrap-foot></table-wrap></p>
      <p id="Par47">Compared to its default threshold of 6.0, SAScore specificity increases by 0.662 (Table <xref rid="Tab5" ref-type="table">5</xref>) when the threshold is shifted to the optimal value of 4.5 (Fig. <xref rid="Fig10" ref-type="fig">10</xref>). At this threshold, SAScore is on par with SYBA and RF methods (Table <xref rid="Tab5" ref-type="table">5</xref>). However, SYBA retains its high performance over much broader range of threshold values than SAScore (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Figure S1).</p>
      <p id="Par48">High performance of SYBA, RF and SAScore is also evident from their <italic>AUC</italic> that is close to one (Fig. <xref rid="Fig9" ref-type="fig">9</xref>, Table <xref rid="Tab5" ref-type="table">5</xref>). On the other hand, SCScore fails to distinguish between ES and HS compounds as can be deduced from its ROC curve (Fig. <xref rid="Fig9" ref-type="fig">9</xref>). In its optimal threshold of 3.1, SCScore predicts a majority of T<sub>CP</sub> compounds as HS (Fig. <xref rid="Fig10" ref-type="fig">10</xref>, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Panel S3).<fig id="Fig9"><label>Fig. 9</label><caption><p>ROC curves of classification models for the T<sub>CP</sub> test set</p></caption><graphic xlink:href="13321_2020_439_Fig9_HTML" id="MO20"/></fig><fig id="Fig10"><label>Fig. 10</label><caption><p>SYBA, SAScore and SCScore histograms of ES and HS compounds in the computationally picked T<sub>CP</sub> test set. The positions of optimal thresholds are shown. SAScore recommended threshold of 6.0 leads to a large number of FP (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Panel S3). If the threshold is moved to its optimal value of 4.5, SAScore specificity increases from 0.317 to 0.994, i.e. by 0.677</p></caption><graphic xlink:href="13321_2020_439_Fig10_HTML" id="MO21"/></fig></p>
      <p id="Par49">In addition to the T<sub>MC</sub> and T<sub>CP</sub> test sets, the performance of SAScore and SCScore was also assessed using the training set S, as this data set was not used for their parametrization. Classification results are shown in Table <xref rid="Tab7" ref-type="table">7</xref> and Fig. <xref rid="Fig11" ref-type="fig">11</xref>, confusion matrices are available in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Panel S4.<table-wrap id="Tab7"><label>Table 7</label><caption><p>The performance of classification models for the training set S</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left"><italic>AUC</italic></th><th align="left"><italic>Acc</italic></th><th align="left"><italic>SN</italic></th><th align="left"><italic>SP</italic></th><th align="left">Threshold</th></tr></thead><tbody><tr><td align="left" colspan="6">Default threshold</td></tr><tr><td align="left">SAScore</td><td char="." align="char">0.981</td><td char="." align="char">0.767</td><td char="." align="char">0.998</td><td char="." align="char">0.536</td><td char="." align="char">6.0</td></tr><tr><td align="left" colspan="6">Optimized threshold</td></tr><tr><td align="left">SAScore</td><td char="." align="char"><italic>0.981</italic></td><td char="." align="char"><italic>0.933</italic></td><td char="." align="char"><italic>0.935</italic></td><td char="." align="char"><italic>0.932</italic></td><td char="." align="char">4.4</td></tr><tr><td align="left">SCScore</td><td char="." align="char">0.667</td><td char="." align="char">0.623</td><td char="." align="char">0.564</td><td char="." align="char">0.682</td><td char="." align="char">3.7</td></tr></tbody></table></table-wrap><fig id="Fig11"><label>Fig. 11</label><caption><p>ROC curves of classification models for the training set S</p></caption><graphic xlink:href="13321_2020_439_Fig11_HTML" id="MO22"/></fig></p>
      <p id="Par50">In agreement with previous experiments on the T<sub>MC</sub> and T<sub>CP</sub> test sets, SAScore is able to distinguish between ES and HS compounds more accurately than SCScore. However, to achieve the best performance, SAScore classification threshold must be shifted from its default value of 6.0 to the optimal value of 4.4. At this threshold, SAScore is both highly sensitive and specific, while SCScore is, using its optimal threshold of 3.7, sensitive and specific only moderately.</p>
      <p id="Par51">The observed poor performance of SCScore in all data sets may follow from the fact that SCScore differs conceptually from other methods tested in the present work. In SCScore, the problem of predicting synthetic complexity is reformulated as the analysis of reactions consisting of reactant-product pairs and SCScore correlates with a number of reaction steps. It means that, contrary to SYBA and SAScore, SCScore captures synthetic feasibility of compounds, not structural complexity. In SCScore derivation, each molecule is analyzed as a whole in the context of all molecules and reactions as they appear in the Reaxys database [<xref ref-type="bibr" rid="CR44">44</xref>]. Thus, SCScore is biased [<xref ref-type="bibr" rid="CR43">43</xref>] by the types of reactants and products in the Reaxys database. Therefore, we hypothesize that the unsatisfactory results of SCScore are caused by the fact that compounds in our data sets come from chemical subspace insufficiently covered by Reaxys compounds.</p>
    </sec>
  </sec>
  <sec id="Sec14">
    <title>Conclusions</title>
    <p id="Par52">In the present work, SYBA method for the classification of organic compounds as easy- and hard-to-synthesize is described. SYBA is an additive fragment-based approach meaning that the compound is decomposed into individual substructure fragments, each fragment is assigned its respective SYBA fragment score and these are summed to obtain the final SYBA score. The fragment scores were derived by the Bayesian analysis of the frequency of ECFP8 fragments occurring in the database of ES compounds, that were randomly chosen from the ZINC15 database [<xref ref-type="bibr" rid="CR57">57</xref>], and HS compounds, that were generated using the Nonpher approach [<xref ref-type="bibr" rid="CR58">58</xref>]. Because SYBA was derived from ECFP8 fragments that utilize only molecular connectivity and no 3D information, the influence of stereochemistry on synthetic accessibility is not accounted for. However, apart from ECFP8 fragments, the number of stereocenters is included in SYBA calculation and the compounds with many stereocenters are penalized. If the SYBA score is positive, the compound is considered to be ES and vice versa. While SYBA score can theoretically assume values between plus and minus infinity, a majority of compounds will have SYBA score between − 100 and +100 in real applications. It must be stressed here that the absolute value of the SYBA score is the measure of the confidence of the prediction and not of the degree of the synthetic accessibility.</p>
    <p id="Par53">SYBA was compared with other two recent classification methods, SAScore [<xref ref-type="bibr" rid="CR45">45</xref>] and SCScore [<xref ref-type="bibr" rid="CR43">43</xref>]. As a baseline for the comparison, RF/ECFP4 classifier was used due to its wide adoption in many cheminformatics applications. All methods were assessed using accuracy, sensitivity, specificity and area under the ROC curve. While SYBA and RF provide similar performance, we recommend to use SYBA due to its smaller complexity, lower computational demands and more straightforward analysis of the individual fragment contributions. SYBA outperforms SAScore when this is used with the threshold of 6.0 proposed by the authors [<xref ref-type="bibr" rid="CR45">45</xref>]. However, if the SAScore threshold is changed to the value of ~ 4.5, the accuracy of SYBA and SAScore becomes comparable. Therefore, to reduce the number of false positives in workflows that utilize SAScore, we recommend to decrease the SAScore threshold to ~ 4.5. SYBA, RF and SAScore substantially outperform SCScore. The observed weak performance of SCScore can be, in our opinion, attributed to the fact that our test set compounds come from a part of chemical space that is insufficiently covered by Reaxys compounds used to derive SCScore. The SYBA fragment scores can be mapped [<xref ref-type="bibr" rid="CR74">74</xref>] onto a molecule and used for the analysis of the contribution of its individual substructures to the overall synthetic accessibility.</p>
    <p id="Par54">SYBA can be used to quickly rank large molecular data sets that originate, for example, from de novo molecular design. However, SYBA is conceptually based on the notion that a compound can be categorized as easy- and hard-to-synthesize. As the synthetic accessibility is a vaguely defined term, SYBA’s simplifying approach, though accurate enough, cannot compete with more sophisticated synthetic path-reconstruction methods that enable the incorporation of other factors such as the availability of starting materials, reaction yields or a price aspect. In the end, the definitive assessment of synthetic accessibility is in the hands of experienced organic chemists.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec15">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13321_2020_439_MOESM1_ESM.zip">
            <caption>
              <p><bold>Additional file 1.</bold> Training set S. It consists of 693 353 ES compounds selected from the ZINC15 database and of 693 353 ES compounds generated by Nonpher.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="13321_2020_439_MOESM2_ESM.docx">
            <caption>
              <p><bold>Additional file 2.</bold> This supporting document contains the detailed description of the SYBA score derivation, threshold values of complexity indices, RF hyperparameter optimization results, the dependence of the accuracy of the classification of TCP compounds on SYBA and SAScore thresholds, examples of correctly predicted and mispredicted S, TMC and TCP compounds, fragments with very low SYBA contributions and HS compounds containing these fragments, and confusion matrices of the classification of TMC, TCP and S data sets.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="13321_2020_439_MOESM3_ESM.zip">
            <caption>
              <p><bold>Additional file 3.</bold> Manually curated test set (TMC). It consists of 40 HS compounds manually selected from scientific papers and of 30 ES sets, each of them contains 40 compounds selected from the ZINC15 database.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="13321_2020_439_MOESM4_ESM.zip">
            <caption>
              <p><bold>Additional file 4.</bold> Computationally picked test set (TCP). It consists of 3 581 HS compounds that were obtained from the GDB-17 database complemented by the same number of compounds randomly selected from the ZINC15 database.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>Acc</term>
        <def>
          <p id="Par2">Accuracy</p>
        </def>
      </def-item>
      <def-item>
        <term>AUC</term>
        <def>
          <p id="Par3">Area under the ROC curve</p>
        </def>
      </def-item>
      <def-item>
        <term>ES</term>
        <def>
          <p id="Par4">Easy-to-synthesize</p>
        </def>
      </def-item>
      <def-item>
        <term>HS</term>
        <def>
          <p id="Par5">Hard-to-synthesize</p>
        </def>
      </def-item>
      <def-item>
        <term>MW</term>
        <def>
          <p id="Par6">Molecular weight</p>
        </def>
      </def-item>
      <def-item>
        <term>RF</term>
        <def>
          <p id="Par7">Random forest</p>
        </def>
      </def-item>
      <def-item>
        <term>ROC</term>
        <def>
          <p id="Par8">Receiver operating characteristic</p>
        </def>
      </def-item>
      <def-item>
        <term>S</term>
        <def>
          <p id="Par9">Training set</p>
        </def>
      </def-item>
      <def-item>
        <term>SN</term>
        <def>
          <p id="Par10">Sensitivity</p>
        </def>
      </def-item>
      <def-item>
        <term>SP</term>
        <def>
          <p id="Par11">Specificity</p>
        </def>
      </def-item>
      <def-item>
        <term>SVD</term>
        <def>
          <p id="Par12">Singular value decomposition</p>
        </def>
      </def-item>
      <def-item>
        <term>SYBA</term>
        <def>
          <p id="Par13">SYnthetic Bayesian Accessibility</p>
        </def>
      </def-item>
      <def-item>
        <term>T<sub>CP</sub></term>
        <def>
          <p id="Par14">Computationally picked test set</p>
        </def>
      </def-item>
      <def-item>
        <term>T<sub>MC</sub></term>
        <def>
          <p id="Par15">Manually curated test set</p>
        </def>
      </def-item>
      <def-item>
        <term>YI</term>
        <def>
          <p id="Par16">Youden index</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13321-020-00439-2.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>Computational resources were supplied by the project “e-Infrastruktura CZ” (e-INFRA LM2018140) provided within the program Projects of Large Research, Development and Innovations Infrastructures.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>MV, MK and DS conceptualized the problem. MV was responsible for method development, implementation and validation. MV also maintains the SYBA GitHub repository. MK derived SYBA and IČ took part in method testing. DS supervised the study, performed statistical analyses and prepared the manuscript with the active participation of MV, MK and IČ. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported from the Ministry of Education of the Czech Republic (RVO 68378050-KAV-NPUI and LM2018130). IČ research was further supported by a specific university research (MSMT No. 20/2015). MK was supported by the project “Center for Tumor Ecology-Research of the Cancer Microenvironment Supporting Cancer Growth and Spread” (Reg. No. CZ.02.1.01/0.0/0.0/16_019/0000785) within the Operational Programme Research, Development and Education.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The code used to train and benchmark SYBA model is available from <ext-link ext-link-type="uri" xlink:href="https://github.com/lich-uct/syba">https://github.com/lich-uct/syba</ext-link> repository. Nonpher is available from <ext-link ext-link-type="uri" xlink:href="https://github.com/lich-uct/nonpher">https://github.com/lich-uct/nonpher</ext-link>.</p>
  </notes>
  <notes id="FPar1" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par55">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bohacek</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>McMartin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Guida</surname>
            <given-names>WC</given-names>
          </name>
        </person-group>
        <article-title>The art and practice of structure-based drug design: a molecular modeling perspective</article-title>
        <source>Med Res Rev</source>
        <year>1996</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>3</fpage>
        <lpage>50</lpage>
        <?supplied-pmid 8788213?>
        <pub-id pub-id-type="pmid">8788213</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Polishchuk</surname>
            <given-names>PG</given-names>
          </name>
          <name>
            <surname>Madzhidov</surname>
            <given-names>TI</given-names>
          </name>
          <name>
            <surname>Varnek</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Estimation of the size of drug-like chemical space based on GDB-17 data</article-title>
        <source>J Comput Aided Mol Des</source>
        <year>2013</year>
        <volume>27</volume>
        <issue>8</issue>
        <fpage>675</fpage>
        <lpage>679</lpage>
        <?supplied-pmid 23963658?>
        <pub-id pub-id-type="pmid">23963658</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ertl</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Cheminformatics analysis of organic substituents: identification of the most common substituents, calculation of substituent properties, and automatic identification of drug-like bioisosteric groups</article-title>
        <source>J Chem Inf Comput Sci</source>
        <year>2003</year>
        <volume>43</volume>
        <issue>2</issue>
        <fpage>374</fpage>
        <lpage>380</lpage>
        <?supplied-pmid 12653499?>
        <pub-id pub-id-type="pmid">12653499</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Reymond</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>van Deursen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Blum</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Ruddigkeit</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Chemical space as a source for new drugs</article-title>
        <source>Medchemcomm</source>
        <year>2010</year>
        <volume>1</volume>
        <issue>1</issue>
        <fpage>30</fpage>
        <lpage>38</lpage>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Llanos</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Leal</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Luu</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Jost</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stadler</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Restrepo</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Exploration of the chemical space and its three historical regimes</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2019</year>
        <volume>116</volume>
        <issue>26</issue>
        <fpage>12660</fpage>
        <lpage>12665</lpage>
        <?supplied-pmid 31186353?>
        <pub-id pub-id-type="pmid">31186353</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karlov</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Sosnin</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tetko</surname>
            <given-names>IV</given-names>
          </name>
          <name>
            <surname>Fedorov</surname>
            <given-names>MV</given-names>
          </name>
        </person-group>
        <article-title>Chemical space exploration guided by deep neural networks</article-title>
        <source>Rsc Advances</source>
        <year>2019</year>
        <volume>9</volume>
        <issue>9</issue>
        <fpage>5151</fpage>
        <lpage>5157</lpage>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gromski</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Henson</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Granda</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Cronin</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>How to explore chemical space using algorithms and automation</article-title>
        <source>Nat Rev Chem</source>
        <year>2019</year>
        <volume>3</volume>
        <issue>2</issue>
        <fpage>119</fpage>
        <lpage>128</lpage>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Walters</surname>
            <given-names>WP</given-names>
          </name>
        </person-group>
        <article-title>Virtual chemical libraries</article-title>
        <source>J Med Chem</source>
        <year>2019</year>
        <volume>62</volume>
        <issue>3</issue>
        <fpage>1116</fpage>
        <lpage>1124</lpage>
        <?supplied-pmid 30148631?>
        <pub-id pub-id-type="pmid">30148631</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Franzini</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Neri</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Scheuermann</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries</article-title>
        <source>Acc Chem Res</source>
        <year>2014</year>
        <volume>47</volume>
        <issue>4</issue>
        <fpage>1247</fpage>
        <lpage>1255</lpage>
        <?supplied-pmid 24673190?>
        <pub-id pub-id-type="pmid">24673190</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lopez-Vallejo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Caulfield</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Martinez-Mayorga</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Giulianotti</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Nefzi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Houghten</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Integrating virtual screening and combinatorial chemistry for accelerated drug discovery</article-title>
        <source>Comb Chem High Throughput Screen</source>
        <year>2011</year>
        <volume>14</volume>
        <issue>6</issue>
        <fpage>475</fpage>
        <lpage>487</lpage>
        <?supplied-pmid 21521151?>
        <pub-id pub-id-type="pmid">21521151</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hoffmann</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gastreich</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The next level in chemical space navigation: going far beyond enumerable compound libraries</article-title>
        <source>Drug Discov Today</source>
        <year>2019</year>
        <volume>24</volume>
        <issue>5</issue>
        <fpage>1148</fpage>
        <lpage>1156</lpage>
        <?supplied-pmid 30851414?>
        <pub-id pub-id-type="pmid">30851414</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Hilten</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Chevillard</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kolb</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Virtual compound libraries in computer-assisted drug discovery</article-title>
        <source>J Chem Inf Model</source>
        <year>2019</year>
        <volume>59</volume>
        <issue>2</issue>
        <fpage>644</fpage>
        <lpage>651</lpage>
        <?supplied-pmid 30624918?>
        <pub-id pub-id-type="pmid">30624918</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fechner</surname>
            <given-names>U</given-names>
          </name>
        </person-group>
        <article-title>Computer-based de novo design of drug-like molecules</article-title>
        <source>Nat Rev Drug Discov</source>
        <year>2005</year>
        <volume>4</volume>
        <issue>8</issue>
        <fpage>649</fpage>
        <lpage>663</lpage>
        <?supplied-pmid 16056391?>
        <pub-id pub-id-type="pmid">16056391</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Loving</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Alberts</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Sherman</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Computational approaches for fragment-based and de novo design</article-title>
        <source>Curr Top Med Chem</source>
        <year>2010</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>14</fpage>
        <lpage>32</lpage>
        <?supplied-pmid 19929832?>
        <pub-id pub-id-type="pmid">19929832</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Martinez-Mayorga</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Meurice</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Balancing novelty with confined chemical space in modern drug discovery</article-title>
        <source>Expert Opin Drug Discov</source>
        <year>2014</year>
        <volume>9</volume>
        <issue>2</issue>
        <fpage>151</fpage>
        <lpage>165</lpage>
        <?supplied-pmid 24350718?>
        <pub-id pub-id-type="pmid">24350718</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schneider</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>De Novo design at the edge of Chaos</article-title>
        <source>J Med Chem</source>
        <year>2016</year>
        <volume>59</volume>
        <issue>9</issue>
        <fpage>4077</fpage>
        <lpage>4086</lpage>
        <?supplied-pmid 26881908?>
        <pub-id pub-id-type="pmid">26881908</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kutchukian</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Shakhnovich</surname>
            <given-names>EI</given-names>
          </name>
        </person-group>
        <article-title>De novo design: balancing novelty and confined chemical space</article-title>
        <source>Expert Opin Drug Discov</source>
        <year>2010</year>
        <volume>5</volume>
        <issue>8</issue>
        <fpage>789</fpage>
        <lpage>812</lpage>
        <?supplied-pmid 22827800?>
        <pub-id pub-id-type="pmid">22827800</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hartenfeller</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>De novo drug design</article-title>
        <source>Methods Mol Biol</source>
        <year>2011</year>
        <volume>672</volume>
        <fpage>299</fpage>
        <lpage>323</lpage>
        <?supplied-pmid 20838974?>
        <pub-id pub-id-type="pmid">20838974</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hartenfeller</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Proschak</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Schuller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization</article-title>
        <source>Chem Biol Drug Des</source>
        <year>2008</year>
        <volume>72</volume>
        <issue>1</issue>
        <fpage>16</fpage>
        <lpage>26</lpage>
        <?supplied-pmid 18564216?>
        <pub-id pub-id-type="pmid">18564216</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vinkers</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>de Jonge</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Daeyaert</surname>
            <given-names>FF</given-names>
          </name>
          <name>
            <surname>Heeres</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Koymans</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>van Lenthe</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Lewi</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Timmerman</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Van Aken</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Janssen</surname>
            <given-names>PA</given-names>
          </name>
        </person-group>
        <article-title>SYNOPSIS: SYNthesize and OPtimize System in Silico</article-title>
        <source>J Med Chem</source>
        <year>2003</year>
        <volume>46</volume>
        <issue>13</issue>
        <fpage>2765</fpage>
        <lpage>2773</lpage>
        <?supplied-pmid 12801239?>
        <pub-id pub-id-type="pmid">12801239</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hartenfeller</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zettl</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Walter</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rupp</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Reisen</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Proschak</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Weggen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Stark</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>DOGS: reaction-driven de novo design of bioactive compounds</article-title>
        <source>PLoS Comput Biol</source>
        <year>2012</year>
        <volume>8</volume>
        <issue>2</issue>
        <fpage>e1002380</fpage>
        <?supplied-pmid 22359493?>
        <pub-id pub-id-type="pmid">22359493</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Stahl</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks</article-title>
        <source>J Comput Aided Mol Des</source>
        <year>2000</year>
        <volume>14</volume>
        <issue>5</issue>
        <fpage>487</fpage>
        <lpage>494</lpage>
        <?supplied-pmid 10896320?>
        <pub-id pub-id-type="pmid">10896320</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fechner</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Flux (1): a virtual synthesis scheme for fragment-based de novo design</article-title>
        <source>J Chem Inf Model</source>
        <year>2006</year>
        <volume>46</volume>
        <issue>2</issue>
        <fpage>699</fpage>
        <lpage>707</lpage>
        <?supplied-pmid 16563000?>
        <pub-id pub-id-type="pmid">16563000</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Engkvist</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Olivecrona</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Blaschke</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>The rise of deep learning in drug discovery</article-title>
        <source>Drug Discov Today</source>
        <year>2018</year>
        <volume>23</volume>
        <issue>6</issue>
        <fpage>1241</fpage>
        <lpage>1250</lpage>
        <?supplied-pmid 29366762?>
        <pub-id pub-id-type="pmid">29366762</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hessler</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Baringhaus</surname>
            <given-names>KH</given-names>
          </name>
        </person-group>
        <article-title>Artificial intelligence in drug design</article-title>
        <source>Molecules.</source>
        <year>2018</year>
        <volume>23</volume>
        <issue>10</issue>
        <fpage>2520</fpage>
        <pub-id pub-id-type="doi">10.3390/molecules23102520</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Deep learning for molecular generation</article-title>
        <source>Future Med Chem</source>
        <year>2019</year>
        <volume>11</volume>
        <issue>6</issue>
        <fpage>567</fpage>
        <lpage>597</lpage>
        <?supplied-pmid 30698019?>
        <pub-id pub-id-type="pmid">30698019</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Popova</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Isayev</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Tropsha</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Deep reinforcement learning for de novo drug design</article-title>
        <source>Sci Adv</source>
        <year>2018</year>
        <volume>4</volume>
        <issue>7</issue>
        <fpage>7885</fpage>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Olivecrona</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Blaschke</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Engkvist</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Molecular de-novo design through deep reinforcement learning</article-title>
        <source>J Cheminform</source>
        <year>2017</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>48</fpage>
        <?supplied-pmid 29086083?>
        <pub-id pub-id-type="pmid">29086083</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blaschke</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Olivecrona</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Engkvist</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Bajorath</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Application of generative autoencoder in de novo molecular design</article-title>
        <source>Mol Inform.</source>
        <year>2018</year>
        <volume>37</volume>
        <issue>1–2</issue>
        <fpage>1700123</fpage>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Segler</surname>
            <given-names>MHS</given-names>
          </name>
          <name>
            <surname>Kogej</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tyrchan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Waller</surname>
            <given-names>MP</given-names>
          </name>
        </person-group>
        <article-title>Generating focused molecule libraries for drug discovery with recurrent neural networks</article-title>
        <source>ACS Cent Sci</source>
        <year>2018</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>120</fpage>
        <lpage>131</lpage>
        <?supplied-pmid 29392184?>
        <pub-id pub-id-type="pmid">29392184</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Müller</surname>
            <given-names>AT</given-names>
          </name>
          <name>
            <surname>Huisman</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Generative recurrent networks for de novo drug design</article-title>
        <source>Mol Inform.</source>
        <year>2018</year>
        <volume>37</volume>
        <issue>1–2</issue>
        <fpage>1700111</fpage>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Merk</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Friedrich</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Grisoni</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>De novo design of bioactive small molecules by artificial intelligence</article-title>
        <source>Mol Inform.</source>
        <year>2018</year>
        <volume>37</volume>
        <issue>1–2</issue>
        <fpage>1700153</fpage>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mendez-Lucio</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>The many roles of molecular complexity in drug discovery</article-title>
        <source>Drug Discov Today</source>
        <year>2017</year>
        <volume>22</volume>
        <issue>1</issue>
        <fpage>120</fpage>
        <lpage>126</lpage>
        <?supplied-pmid 27575998?>
        <pub-id pub-id-type="pmid">27575998</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bertz</surname>
            <given-names>SH</given-names>
          </name>
        </person-group>
        <article-title>The first general index of molecular complexity</article-title>
        <source>J Am Chem Soc</source>
        <year>1981</year>
        <volume>103</volume>
        <issue>12</issue>
        <fpage>3599</fpage>
        <lpage>3601</lpage>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Whitlock</surname>
            <given-names>HW</given-names>
          </name>
        </person-group>
        <article-title>On the structure of total synthesis of complex natural products</article-title>
        <source>J Organic Chem</source>
        <year>1998</year>
        <volume>63</volume>
        <issue>22</issue>
        <fpage>7982</fpage>
        <lpage>7989</lpage>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Barone</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Chanon</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>A new and simple approach to chemical complexity application to the synthesis of natural products</article-title>
        <source>J Chem Inf Comp Sci</source>
        <year>2001</year>
        <volume>41</volume>
        <issue>2</issue>
        <fpage>269</fpage>
        <lpage>272</lpage>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Allu</surname>
            <given-names>TK</given-names>
          </name>
          <name>
            <surname>Oprea</surname>
            <given-names>TI</given-names>
          </name>
        </person-group>
        <article-title>Rapid evaluation of synthetic and molecular complexity for in silico chemistry</article-title>
        <source>J Chem Inf Model</source>
        <year>2005</year>
        <volume>45</volume>
        <issue>5</issue>
        <fpage>1237</fpage>
        <lpage>1243</lpage>
        <?supplied-pmid 16180900?>
        <pub-id pub-id-type="pmid">16180900</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Selzer</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Ertl</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schuffenhauer</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Complex molecules: do they add value?</article-title>
        <source>Curr Opin Chem Biol</source>
        <year>2005</year>
        <volume>9</volume>
        <issue>3</issue>
        <fpage>310</fpage>
        <lpage>316</lpage>
        <?supplied-pmid 15939334?>
        <pub-id pub-id-type="pmid">15939334</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheridan</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Zorn</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sherer</surname>
            <given-names>EC</given-names>
          </name>
          <name>
            <surname>Campeau</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>CZ</given-names>
          </name>
          <name>
            <surname>Cumming</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Maddess</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Nantermet</surname>
            <given-names>PG</given-names>
          </name>
          <name>
            <surname>Sinz</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>O’Shea</surname>
            <given-names>PD</given-names>
          </name>
        </person-group>
        <article-title>Modeling a crowdsourced definition of molecular complexity</article-title>
        <source>J Chem Inf Model</source>
        <year>2014</year>
        <volume>54</volume>
        <issue>6</issue>
        <fpage>1604</fpage>
        <lpage>1616</lpage>
        <?supplied-pmid 24802889?>
        <pub-id pub-id-type="pmid">24802889</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gillet</surname>
            <given-names>VJ</given-names>
          </name>
          <name>
            <surname>Myatt</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zsoldos</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>AP</given-names>
          </name>
        </person-group>
        <article-title>SPROUT, HIPPO and CAESA: tools for de novo structure generation and estimation of synthetic accessibility</article-title>
        <source>Perspect Drug Discov Des</source>
        <year>1995</year>
        <volume>3</volume>
        <fpage>34</fpage>
        <lpage>50</lpage>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L-L</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>S-Y</given-names>
          </name>
        </person-group>
        <article-title>RASA: a rapid retrosynthesis-based scoring method for the assessment of synthetic accessibility of drug-like molecules</article-title>
        <source>J Chem Inf Model</source>
        <year>2011</year>
        <volume>51</volume>
        <issue>10</issue>
        <fpage>2768</fpage>
        <lpage>2777</lpage>
        <?supplied-pmid 21932860?>
        <pub-id pub-id-type="pmid">21932860</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Eastgate</surname>
            <given-names>MD</given-names>
          </name>
        </person-group>
        <article-title>Current complexity: a tool for assessing the complexity of organic molecules</article-title>
        <source>Org Biomol Chem</source>
        <year>2015</year>
        <volume>13</volume>
        <issue>26</issue>
        <fpage>7164</fpage>
        <lpage>7176</lpage>
        <?supplied-pmid 25962620?>
        <pub-id pub-id-type="pmid">25962620</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Coley</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Rogers</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>KF</given-names>
          </name>
        </person-group>
        <article-title>SCScore: synthetic complexity learned from a reaction corpus</article-title>
        <source>J Chem Inf Model</source>
        <year>2018</year>
        <volume>58</volume>
        <issue>2</issue>
        <fpage>252</fpage>
        <lpage>261</lpage>
        <?supplied-pmid 29309147?>
        <pub-id pub-id-type="pmid">29309147</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <mixed-citation publication-type="other">Reaxys. <ext-link ext-link-type="uri" xlink:href="https://www.reaxys.com">https://www.reaxys.com</ext-link>. Accessed 24 January 2020</mixed-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ertl</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schuffenhauer</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions</article-title>
        <source>J Cheminf</source>
        <year>2009</year>
        <volume>1</volume>
        <fpage>1</fpage>
        <lpage>11</lpage>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rogers</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hahn</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Extended-connectivity fingerprints</article-title>
        <source>J Chem Inf Model</source>
        <year>2010</year>
        <volume>50</volume>
        <issue>5</issue>
        <fpage>742</fpage>
        <lpage>754</lpage>
        <?supplied-pmid 20426451?>
        <pub-id pub-id-type="pmid">20426451</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gindulyte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Shoemaker</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Thiessen</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PubChem 2019 update: improved access to chemical data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D1102</fpage>
        <lpage>D1109</lpage>
        <?supplied-pmid 30371825?>
        <pub-id pub-id-type="pmid">30371825</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Besnard</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ruda</surname>
            <given-names>GF</given-names>
          </name>
          <name>
            <surname>Setola</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Abecassis</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rodriguiz</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>XP</given-names>
          </name>
          <name>
            <surname>Norval</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sassano</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Shin</surname>
            <given-names>AI</given-names>
          </name>
          <name>
            <surname>Webster</surname>
            <given-names>LA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Automated design of ligands to polypharmacological profiles</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>492</volume>
        <issue>7428</issue>
        <fpage>215</fpage>
        <lpage>220</lpage>
        <?supplied-pmid 23235874?>
        <pub-id pub-id-type="pmid">23235874</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yoshizoe</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Terayama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tsuda</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>ChemTS: an efficient python library for de novo molecular generation</article-title>
        <source>Sci Technol Adv Mater</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>972</fpage>
        <lpage>976</lpage>
        <?supplied-pmid 29435094?>
        <pub-id pub-id-type="pmid">29435094</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chevillard</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Kolb</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>SCUBIDOO: a large yet screenable and easily searchable database of computationally created chemical compounds optimized toward high likelihood of synthetic tractability</article-title>
        <source>J Chem Inf Model</source>
        <year>2015</year>
        <volume>55</volume>
        <issue>9</issue>
        <fpage>1824</fpage>
        <lpage>1835</lpage>
        <?supplied-pmid 26282054?>
        <pub-id pub-id-type="pmid">26282054</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Clark</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Dole</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Coulon-Spektor</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>McNutt</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Grass</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Freundlich</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Reynolds</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Ekins</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Open source Bayesian Models. 1. Application to ADME/Tox and drug discovery datasets</article-title>
        <source>J Chem Inf Model</source>
        <year>2015</year>
        <volume>55</volume>
        <issue>6</issue>
        <fpage>1231</fpage>
        <lpage>1245</lpage>
        <?supplied-pmid 25994950?>
        <pub-id pub-id-type="pmid">25994950</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xia</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Maliski</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Gallant</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rogers</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Classification of kinase inhibitors using a Bayesian model</article-title>
        <source>J Med Chem</source>
        <year>2004</year>
        <volume>47</volume>
        <issue>18</issue>
        <fpage>4463</fpage>
        <lpage>4470</lpage>
        <?supplied-pmid 15317458?>
        <pub-id pub-id-type="pmid">15317458</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bender</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Bayesian methods in virtual screening and chemical biology</article-title>
        <source>Methods Mol Biol</source>
        <year>2011</year>
        <volume>672</volume>
        <fpage>175</fpage>
        <lpage>196</lpage>
        <?supplied-pmid 20838969?>
        <pub-id pub-id-type="pmid">20838969</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vogt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bajorath</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Introduction of an information-theoretic method to predict recovery rates of active compounds for Bayesian in silico screening: theory and screening trials</article-title>
        <source>J Chem Inf Model</source>
        <year>2007</year>
        <volume>47</volume>
        <issue>2</issue>
        <fpage>337</fpage>
        <lpage>341</lpage>
        <?supplied-pmid 17302401?>
        <pub-id pub-id-type="pmid">17302401</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koutsoukas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lowe</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kalantarmotamedi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mussa</surname>
            <given-names>HY</given-names>
          </name>
          <name>
            <surname>Klaffke</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Mitchell</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Glen</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Bender</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naive Bayes and Parzen-Rosenblatt window</article-title>
        <source>J Chem Inf Model</source>
        <year>2013</year>
        <volume>53</volume>
        <issue>8</issue>
        <fpage>1957</fpage>
        <lpage>1966</lpage>
        <?supplied-pmid 23829430?>
        <pub-id pub-id-type="pmid">23829430</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Irwin</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Sterling</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mysinger</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Bolstad</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Coleman</surname>
            <given-names>RG</given-names>
          </name>
        </person-group>
        <article-title>ZINC: a free tool to discover chemistry for biology</article-title>
        <source>J Chem Inf Model</source>
        <year>2012</year>
        <volume>52</volume>
        <issue>7</issue>
        <fpage>1757</fpage>
        <lpage>1768</lpage>
        <?supplied-pmid 22587354?>
        <pub-id pub-id-type="pmid">22587354</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sterling</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Irwin</surname>
            <given-names>JJ</given-names>
          </name>
        </person-group>
        <article-title>ZINC 15—ligand discovery for everyone</article-title>
        <source>J Chem Inf Model</source>
        <year>2015</year>
        <volume>55</volume>
        <issue>11</issue>
        <fpage>2324</fpage>
        <lpage>2337</lpage>
        <?supplied-pmid 26479676?>
        <pub-id pub-id-type="pmid">26479676</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Voršilák</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Svozil</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Nonpher: computational method for design of hard-to-synthesize structures</article-title>
        <source>J Cheminf</source>
        <year>2017</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>20</lpage>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hoksza</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Skoda</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Vorsilak</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Svozil</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Molpher: a software framework for systematic chemical space exploration</article-title>
        <source>J Cheminf</source>
        <year>2014</year>
        <volume>6</volume>
        <fpage>1</fpage>
        <lpage>13</lpage>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <mixed-citation publication-type="other">RDKit: open-source cheminformatics. <ext-link ext-link-type="uri" xlink:href="http://www.rdkit.org">http://www.rdkit.org</ext-link>. Accessed 24 January 2020</mixed-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruddigkeit</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>van Deursen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Blum</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Reymond</surname>
            <given-names>J-L</given-names>
          </name>
        </person-group>
        <article-title>Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17</article-title>
        <source>J Chem Inf Model</source>
        <year>2012</year>
        <volume>52</volume>
        <issue>11</issue>
        <fpage>2864</fpage>
        <lpage>2875</lpage>
        <?supplied-pmid 23088335?>
        <pub-id pub-id-type="pmid">23088335</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boda</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Seidel</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gasteiger</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Structure and reaction based evaluation of synthetic accessibility</article-title>
        <source>J Comput-Aided Mol Des</source>
        <year>2007</year>
        <volume>21</volume>
        <issue>6</issue>
        <fpage>311</fpage>
        <lpage>325</lpage>
        <?supplied-pmid 17294248?>
        <pub-id pub-id-type="pmid">17294248</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fukunishi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kurosawa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mikami</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Prediction of synthetic accessibility based on commercially available compound databases</article-title>
        <source>J Chem Inf Model</source>
        <year>2014</year>
        <volume>54</volume>
        <issue>12</issue>
        <fpage>3259</fpage>
        <lpage>3267</lpage>
        <?supplied-pmid 25420000?>
        <pub-id pub-id-type="pmid">25420000</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheridan</surname>
            <given-names>RP</given-names>
          </name>
        </person-group>
        <article-title>Using random forest to model the domain applicability of another random forest model</article-title>
        <source>J Chem Inf Model</source>
        <year>2013</year>
        <volume>53</volume>
        <issue>11</issue>
        <fpage>2837</fpage>
        <lpage>2850</lpage>
        <?supplied-pmid 24152204?>
        <pub-id pub-id-type="pmid">24152204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kensert</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Alvarsson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Norinder</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Spjuth</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <article-title>Evaluating parameters for ligand-based modeling with random forest on sparse data sets</article-title>
        <source>J Cheminform</source>
        <year>2018</year>
        <volume>10</volume>
        <issue>1</issue>
        <fpage>49</fpage>
        <?supplied-pmid 30306349?>
        <pub-id pub-id-type="pmid">30306349</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Svetnik</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Liaw</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tong</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Culberson</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Sheridan</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Feuston</surname>
            <given-names>BP</given-names>
          </name>
        </person-group>
        <article-title>Random forest: a classification and regression tool for compound classification and QSAR modeling</article-title>
        <source>J Chem Inf Comput Sci</source>
        <year>2003</year>
        <volume>43</volume>
        <issue>6</issue>
        <fpage>1947</fpage>
        <lpage>1958</lpage>
        <?supplied-pmid 14632445?>
        <pub-id pub-id-type="pmid">14632445</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pedregosa</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Varoquaux</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gramfort</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Michel</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Thirion</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Grisel</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Blondel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Prettenhofer</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dubourg</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Scikit-learn: machine Learning in Python</article-title>
        <source>J Mach Learn Res</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>2825</fpage>
        <lpage>2830</lpage>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <mixed-citation publication-type="other">SCScore GitHub. <ext-link ext-link-type="uri" xlink:href="https://github.com/connorcoley/scscore">https://github.com/connorcoley/scscore</ext-link>. Accessed 24 January 2020</mixed-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Youden</surname>
            <given-names>WJ</given-names>
          </name>
        </person-group>
        <article-title>Index for rating diagnostic tests</article-title>
        <source>Cancer</source>
        <year>1950</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>32</fpage>
        <lpage>35</lpage>
        <?supplied-pmid 15405679?>
        <pub-id pub-id-type="pmid">15405679</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fluss</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Faraggi</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Reiser</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Estimation of the Youden Index and its associated cutoff point</article-title>
        <source>Biom J</source>
        <year>2005</year>
        <volume>47</volume>
        <issue>4</issue>
        <fpage>458</fpage>
        <lpage>472</lpage>
        <?supplied-pmid 16161804?>
        <pub-id pub-id-type="pmid">16161804</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Looney</surname>
            <given-names>SW</given-names>
          </name>
        </person-group>
        <article-title>A statistical technique for comparing the accuracies of several classifiers</article-title>
        <source>Pattern Recogn Lett</source>
        <year>1988</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>5</fpage>
        <lpage>9</lpage>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Westfall</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Troendle</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Pennello</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Multiple McNemar tests</article-title>
        <source>Biometrics</source>
        <year>2010</year>
        <volume>66</volume>
        <issue>4</issue>
        <fpage>1185</fpage>
        <lpage>1191</lpage>
        <?supplied-pmid 20345498?>
        <pub-id pub-id-type="pmid">20345498</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamini</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hochberg</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Controlling the false discovery rate—a practical and powerful approach to multiple testing</article-title>
        <source>J R Stat Soc Series B Stat Methodol</source>
        <year>1995</year>
        <volume>57</volume>
        <issue>1</issue>
        <fpage>289</fpage>
        <lpage>300</lpage>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Riniker</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Landrum</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>Similarity maps—a visualization strategy for molecular fingerprints and machine-learning methods</article-title>
        <source>J Cheminform</source>
        <year>2013</year>
        <volume>5</volume>
        <issue>1</issue>
        <fpage>43</fpage>
        <?supplied-pmid 24063533?>
        <pub-id pub-id-type="pmid">24063533</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
